A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2011
10/06/2011	US20110245152 Antibiotic antimicrobial agents and methods of their use
10/06/2011	US20110245151 Bacteriocins and Novel Bacterial Strains
10/06/2011	US20110245150 Targets for treatment of chlamydial infections
10/06/2011	US20110245149 Methods to prevent and treat diseases
10/06/2011	US20110245147 Activation of Peptide Prodrugs by HK2
10/06/2011	US20110245146 Non-Viral Delivery of Compounds to Mitochondria
10/06/2011	US20110245145 Methods and reagents for the diagnosis, prevention and treatment of insulin resistance
10/06/2011	US20110244568 Rna sequence-specific mediators of rna interference
10/06/2011	US20110244564 Cystine knot molecules
10/06/2011	US20110244561 siRNA-MEDIATED GENE SILENCING
10/06/2011	US20110244507 USE OF NEUREGULIN-ß AS AN INDICATOR AND/OR TARGET
10/06/2011	US20110244491 Peptides derived from human bplp protein, polynucleotides coding for said peptides and antibodies directed against said peptides
10/06/2011	US20110244446 Rna sequence-specific mediators of rna interference
10/06/2011	US20110244053 Use a goat serum for veterinary treatment
10/06/2011	US20110244044 Compound, medicament, vaccine composition and nanocapsules
10/06/2011	US20110244039 Absorbable solid compositions for topical treatment of oral mucosal disorders
10/06/2011	US20110244032 Dispersible phospholipid stabilized microparticles
10/06/2011	US20110244027 2'-Fluoro-6'-Methylene Carbocyclic Nucleosides and Methods of Treating Viral Infections
10/06/2011	US20110244023 Transdermal delivery patch
10/06/2011	US20110244019 Absorbent fabric implant
10/06/2011	US20110244017 Absorbable Coating For Implantable Device
10/06/2011	US20110244015 Implantable device for the delivery of octreotide and methods of use thereof
10/06/2011	US20110244014 Implantable medical articles having laminin coatings and methods of use
10/06/2011	US20110244006 Microsphere skin treatment
10/06/2011	US20110244005 Controlled release cgrp delivery composition for cardiovascular and renal indications
10/06/2011	US20110243997 Film-form preparation and method for producing the same
10/06/2011	US20110243995 Method for Rational Mutagenesis of Alpha/Beta T-Cell Receptors and Correspondingly Mutated MDM2-Protein Specific Alpha/Beta T-Cell Receptors
10/06/2011	US20110243980 Methods and systems for o-glycosylating proteins
10/06/2011	US20110243974 Novel tumor antigen protein sart-3 and tumor antigen peptides thereof
10/06/2011	US20110243967 Molecular complexes which modify immune responses
10/06/2011	US20110243964 Treatment of orthopedic conditions
10/06/2011	US20110243957 Materials and methods for preventing or treating neurodegenerative conditions associated with abeta peptide accumulation
10/06/2011	US20110243956 Methods of diagnosing and treating complications of pregnancy
10/06/2011	US20110243952 Compound and method for regulating plasminogen activation and cell migration
10/06/2011	US20110243945 Anti-Inflammatory Agents
10/06/2011	US20110243939 Modification of nucleic acid vectors with polymers comprising charged quaternary amino groups
10/06/2011	US20110243937 Targeting pax2 for the treatment of breast cancer
10/06/2011	US20110243930 Compositions and methods for the treatment of immune related diseases
10/06/2011	US20110243927 Methods of inhibiting tumor growth using beta 5 integrin antagonists
10/06/2011	US20110243923 Organic compounds
10/06/2011	US20110243922 Genetic Alterations Associated with Type I Diabetes and Methods of Use Thereof for Diagnosis and Treatment
10/06/2011	US20110243921 Prevention and treatment of cutaneous lupus erythematosus
10/06/2011	US20110243920 Compositions and methods for treating collagen-mediated diseases
10/06/2011	US20110243919 Compositions and Methods for Treating Collagen-Mediated Diseases
10/06/2011	US20110243918 Topical medication for the treatment of hemorrhoids and method of use
10/06/2011	US20110243917 Composition for the prevention and treatment of absence seizures comprising pkc agonist as an effective ingredient
10/06/2011	US20110243916 Modified endolysin ply511
10/06/2011	US20110243915 Antimicrobial agents
10/06/2011	US20110243914 Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3 expressing tumors
10/06/2011	US20110243913 Biomaterial Compositions and Methods of Use
10/06/2011	US20110243912 Growth Factor Binding Constructs Materials and Methods
10/06/2011	US20110243911 Use of a compound capable of reducing the uric acid level for the prevention and/or the treatment of lung inflammation and fibrosis
10/06/2011	US20110243910 mammalian rna dependent rna polymerase
10/06/2011	US20110243909 Compositions and Methods for Treating Collagen-Mediated Diseases
10/06/2011	US20110243908 Compositions and Methods for Treating Collagen-Mediated Diseases
10/06/2011	US20110243899 Wnt Signaling Inhibitor Comprising Insulin-Like Growth Factor-Binding Protein
10/06/2011	US20110243894 Methods of treating hepatitis c virus infection
10/06/2011	US20110243893 Markers for determination of patient responsiveness
10/06/2011	US20110243892 Y-shape branched hydrophilic polymer derivatives, their preparation methods, conjugates of the derivatives and drug molecules, and pharmaceutical compositions comprising the conjugates
10/06/2011	US20110243891 Dihydropyrazolopyrimidinone derivative
10/06/2011	US20110243890 Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells With a Virus
10/06/2011	US20110243889 Opioid and opioid-like compounds and uses thereof
10/06/2011	US20110243888 Il-29 mutants and uses thereof
10/06/2011	US20110243887 Il-7 fusion proteins
10/06/2011	US20110243886 Compounds and pharmaceutical compositions for the treatment of viral infections
10/06/2011	US20110243883 Polymeric biolubricants for medical use
10/06/2011	US20110243879 Methods of treating hepatic encephalopathy
10/06/2011	US20110243854 Methods and systems for identifying modulators of longevity
10/06/2011	US20110243845 Somatostatin analogs with inhibitory activity to growth hormone release
10/06/2011	US20110243842 Mammalian receptor proteins; related reagents and methods
10/06/2011	US20110243841 Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells
10/06/2011	US20110240012 Recombinant human cc10 and compositions thereof for use in the treatment of nasal rhinitis
10/06/2011	DE102010013887A1 Fusionsprotein und dessen Verwendungen Fusion protein and uses thereof
10/06/2011	DE102010013587A1 N-(Aminoacyl)-Amino-Ester N- (aminoacyl) -amino-ester
10/06/2011	CA2796567A1 Composition comprising insulin and herbal oil for transdermal or transmucosal administration
10/06/2011	CA2795400A1 Prevention and treatment of cast nephropathy
10/06/2011	CA2795291A1 An insulin conjugate using an immunoglobulin fragment
10/06/2011	CA2794930A1 Method for inhibiting hiv replication in mammal and human cells
10/06/2011	CA2794782A1 Botulinum toxin dosage regimen for chronic migraine prophylaxis
10/06/2011	CA2794674A1 Frizzled-binding agents and uses thereof
10/06/2011	CA2794334A1 Derivatives of 1-amino-2-cyclopropylethylboronic acid
10/06/2011	CA2794305A1 Compositions and methods for the removal of biofilms
10/06/2011	CA2793919A1 Fertilization prediction and promotion
10/06/2011	CA2793692A1 Methods for treating parkinson's disease and other disorders of dopaminergic neurons of the brain
10/06/2011	CA2793485A1 A fast dissolving pharmaceutical composition
10/06/2011	CA2793405A1 A fast dissolving pharmaceutical composition
10/06/2011	CA2790257A1 Implant cannula having an implant and method for securing implants in an injection cannula
10/05/2011	EP2371962A2 Receptor activator of NF-KAPPA B, receptor is member of TNF receptor superfamily
10/05/2011	EP2371955A1 Integrase cofactor
10/05/2011	EP2371861A1 Monoclonal antibodies against extracellular loops of C5aR
10/05/2011	EP2371858A2 Human-Murine chimeric antibodies against respiratory syncytial virus
10/05/2011	EP2371857A1 Factor XII inhibitors for treating interstitial lung disease
10/05/2011	EP2371855A1 Tissue protective peptides and uses thereof
10/05/2011	EP2371853A2 Insulin derivatives or its pharmaceutically acceptable salt, pharmaceutical composition, use of insulin derivative or its pharmaceutically acceptable salt and method of treatment
10/05/2011	EP2371852A2 Epitope analogues
10/05/2011	EP2371851A2 Epitope analogues
10/05/2011	EP2371850A2 Epitope analogues
10/05/2011	EP2371847A1 Peptides and their derived type APL of the HSP60 and pharmaceutical compositions
10/05/2011	EP2371846A1 Voltage dependent anion channel (vdac1) compositions and methods of use thereof for regulating apoptosis
10/05/2011	EP2371840A1 Novel polypeptide having angiogenesis-inducing activity and antibacterial activity, and use thereof for medical purposes

1 ... 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 ... 3163